Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence.

Biliotti E, Zacharia S, Grieco S, Spaziante M, Giusto M, Merli M, Gallinaro V, Taliani G.

J Chemother. 2012 Dec;24(6):369-72. doi: 10.1179/1973947812Y.0000000046.

PMID:
23174103
2.

Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin.

Potthoff A, Berg T, Wedemeyer H; HEP-NET B/C Coinfection Study Group.

Scand J Gastroenterol. 2009;44(12):1487-90. doi: 10.3109/00365520903329585.

PMID:
19900055
3.

Drug induced hypersensitivity syndrome by triple therapy of peginterferon alpha2b, ribavirin and telaprevir in patient with double positive for HBV and HCV.

Takagi H, Hoshino T, Naganuma A, Koitabashi E, Uehara S, Sakamoto N, Kudo T, Ryusaki K, Kakizaki S, Okamoto H.

Hepatogastroenterology. 2013 Oct;60(127):1557-60.

PMID:
24627926
4.

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.

Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, Yang HC, Chen PJ, Chen DS, Liu CJ; Taiwan Liver-Net Consortium.

Hepatology. 2013 Jun;57(6):2135-42. doi: 10.1002/hep.26266. Epub 2013 Apr 26.

PMID:
23322699
5.

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS.

Gastroenterology. 2009 Feb;136(2):496-504.e3. doi: 10.1053/j.gastro.2008.10.049. Epub 2008 Oct 29.

PMID:
19084016
6.

The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.

Perrakis A, Yedibela S, Schuhmann S, Croner R, Schellerer V, Demir R, Hohenberger W, Müller V.

Transplant Proc. 2011 Dec;43(10):3824-8. doi: 10.1016/j.transproceed.2011.08.103.

PMID:
22172854
7.

Treatment of HBV/HCV coinfection: releasing the enemy within.

Gordon SC, Sherman KE.

Gastroenterology. 2009 Feb;136(2):393-6. doi: 10.1053/j.gastro.2008.12.017. Epub 2008 Dec 25. No abstract available.

PMID:
19105960
8.

Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.

Fontana RJ, Hughes EA, Appelman H, Hindes R, Dimitrova D, Bifano M.

Liver Transpl. 2012 Sep;18(9):1053-9. doi: 10.1002/lt.23482.

9.

Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C.

Loulergue P, Mir O, Sogni P.

AIDS. 2012 Mar 13;26(5):655-6. doi: 10.1097/QAD.0b013e3283519397. No abstract available.

PMID:
22398573
10.

Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant.

Kwo PY, Ghabril M, Lacerda MA, Joseph Tector A, Fridell JA, Vianna R.

Clin Transplant. 2014 Jun;28(6):722-7. doi: 10.1111/ctr.12372. Epub 2014 May 14.

PMID:
24708229
11.

[Peginterferon-alfa-2b or -alfa-2a and ribavirin combined treatment in hepatitis C infection].

Szalay F.

Orv Hetil. 2010 Feb 14;151(7):271-3. doi: 10.1556/OH.2010.28801. Hungarian. No abstract available.

PMID:
20133247
12.

[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].

Makara M, Horváth G, Gervain J, Pár A, Szalay F, Telegdy L, Tornai I, Ujhelyi E, Hunyady B.

Orv Hetil. 2012 Mar 11;153(10):375-94. doi: 10.1556/OH.2012.29338. Hungarian.

PMID:
22370225
13.

Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.

Sagnelli E, Pisaturo M, Martini S, Sagnelli C, Filippini P, Coppola N.

Expert Opin Pharmacother. 2014 Jul;15(10):1337-49. doi: 10.1517/14656566.2014.913571. Epub 2014 Apr 29. Review.

PMID:
24773464
14.

Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.

Hung CH, Lu SN, Wang JH, Hu TH, Chen CH, Huang CM, Lee CM.

Antivir Ther. 2011;16(7):959-68. doi: 10.3851/IMP1842.

PMID:
22024511
15.

Impact of hepatitis B virus integration into liver tissue on the efficacy of peginterferon and ribavirin therapy in hepatitis B virus-negative chronic hepatitis C patients.

Toyoda H, Kumada T, Tada T, Murakami Y.

J Clin Gastroenterol. 2014 Jan;48(1):73-9. doi: 10.1097/MCG.0b013e31829c409d.

PMID:
23842217
16.

Current management and perspectives for HCV recurrence after liver transplantation.

Coilly A, Roche B, Samuel D.

Liver Int. 2013 Feb;33 Suppl 1:56-62. doi: 10.1111/liv.12062. Review.

PMID:
23286847
17.

Treatment of hepatitis B and C following liver transplantation.

Sponseller CA, Ramrakhiani S.

Curr Gastroenterol Rep. 2002 Feb;4(1):52-62. Review.

PMID:
11825542
18.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2015 Jan 2;29(1):53-8. doi: 10.1097/QAD.0000000000000516.

PMID:
25387314
19.

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC.

AIDS. 2013 Oct 23;27(16):2655-7. doi: 10.1097/01.aids.0000432539.77711.f4.

PMID:
23939241
20.

Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.

Rautou PE, Asselah T, Saadoun D, Martinot M, Valla D, Marcellin P.

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):1019-22.

PMID:
16894318
Items per page

Supplemental Content

Write to the Help Desk